| Clinical indication for anticoagulation | Percentage of patients with low thromboembolic risk | Percentage of patients with high thromboembolic risk |
|---|---|---|
| AF | 39.3 | 0 |
| AF + acquired thrombophilic conditions | 0 | 17 |
| AF + metallic valve replacement | 0 | 10 |
| AF + PE | 0 | 4.3 |
| AVR | 6 | 0 |
| MVR | 0 | 3.4 |
| MR + MS | 0.8 | 0 |
| Venous thromboembolism | 9.0 | 9.4 |
| DVT prophylaxis due to ACTH secreting tumour | 0.8 | 0 |